CANC Market Analysis

Composition

Holdings as published by the issuer · refreshed weekly
Net assets$193.3M
Expense ratio0.75%
Dividend yield0.12%
InceptionAug 14, 2023

Top holdings (60 total)

#NameWeight
1
RVMD
Revolution Medicines inc Ordinary Shares
6.05%
2
LLY
Eli Lilly and co
4.93%
3
COGT
Cogent Biosciences inc
4.92%
4
Novartis ag Registered Shares
4.01%
5
Roche Holding ag adr
3.76%
6
MRK
Merck & co inc
3.39%
7
JNJ
Johnson & Johnson
3.34%
8
LEGN
Legend Biotech Corp adr
3.27%
9
BMY
Bristol-myers Squibb co
3.25%
10
ABBV
Abbvie inc
3.23%
Page 1 of 6 · 60 total

Sector breakdown

#NameWeight
1
Healthcare
83.10%
2
Materials
2.70%
3
Information Technology
0.00%
4
Communication Services
0.00%
5
Consumer Discretionary
0.00%
6
Consumer Staples
0.00%
7
Industrials
0.00%
8
Utilities
0.00%
9
Energy
0.00%
10
Financials
0.00%
Page 1 of 2 · 11 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

News & Sentiment

24 articles · sorted by date
Page 1 of 2 · 24 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer